Search clinical trials for: Fospropofol disodium

Total 9675 results

Eisai Inc.

Completed

A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations

Sedation

United States
West China Hospital

Completed

A Study to Assess the Efficacy and Safety of Fospropofol Disodium

Drug Safety

China
Tongji Hospital

Not yet recruiting

ED90 of Fospropofol Disodium in Induction and Maintenance of Anesthesia

Elective Surgery

China
Eisai Inc.
Omnicare Clinical Research; MDS Pharma Services; Bio Analytical Research Corporation and other collaborators

Completed

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

Colonoscopy | Colon Polyps
Eisai Inc.

Completed

GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting

Intubation | Respiration, Artificial | Postoperative Sedation

United States
Eisai Inc.
PPD; Covance; Quest Pharmaceutical Services

Terminated

A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy

Flexible Bronchoscopy
Eisai Inc.
PPD; Covance

Terminated

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures

Osteotomy | Carpal Tunnel | Arthroscopy | Bunionectomy
Eisai Inc.

Completed

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy

Anesthesia | Bronchoscopy

United States
Eisai Inc.
PPD; Covance; Quest Pharmaceutical Services

Terminated

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy

Colonoscopy | Colon Polyps
Eisai Inc.
PPD; Covance

Completed

Study to Assess Safety and Efficacy of AQUAVAN® Injection for Sedation During Cardiac Catheterization

Angioplasty | Coronary Catheterization
Eisai Inc.
PPD; MDS Pharma Services; Bio Analytical Research Corporation; Coghlan Group (Plasma...

Completed

A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy

Colonoscopy | Colon Polyps
Henan Provincial People's Hospital

Not yet recruiting

Safety and Efficacy of Fospropofol vs Propofol During Invasive Mechanical Ventilation.

Invasive Mechanical Ventilation
Eisai Inc.

Completed

A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures.

Procedural Sedation

United States
Eisai Inc.

Completed

A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion

Anesthesia

United States
Eisai Inc.
PPD

Completed

Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery

Coronary Artery Bypass Surgery | Ischemic Coronary Artery Disease
Grace Shih, MD

Withdrawn

Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia

Interstitial Cystitis
Xiaobo Yang, MD

Recruiting

Efficacy and Safety of Fospropofol Disodium Versus Propofol for Deep Sedation in Critically Ill Patients

Critical Illness

China
Xiaobo Yang, MD

Completed

Efficacy and Safety of Fospropofol Disodium Versus Propofol for Sedation in Mechanically Ventilated ICU Patients

Critical Illness

China
Shanghai 6th People's Hospital

Not yet recruiting

Efficacy and Safety of Fospropofol for Same-day Bidirectional Endoscopy in Elderly Patients

Elderly Patients
The Cleveland Clinic
Eisai Inc.

Withdrawn

Fospropofol for Sedation During Elective Awake Intubation

Impaired Airway Clearance

United States
Eisai Inc.

Completed

Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy

Colonic Polyps | Colonoscopy

United States
Eisai Inc.

Completed

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy

Conscious Sedation

United States
Mayo Clinic
Eisai Inc.

Terminated

Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

Orthopedic Surgery | Procedural Sedation | Regional Anesthesia Block

United States
Eisai Inc.

Completed

A Study to Assess the Transfer of Fospropofol and Its Active Metabolite, Propofol, to Breast Milk Following Administration of LUSEDRA to Lactating Women Undergoing a Needed Procedure

Lactating Women

United States
Rigel Pharmaceuticals

Completed

Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma

T Cell Lymphoma

United States, Canada
Eisai Inc.

Completed

A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

Monitored Anesthesia Care

United States
NYU Langone Health
Eisai Inc.

Completed

Preventing Propofol Injection Pain: Prospective Randomized Trial Comparing Propofol Versus Fospropofol

Pain | Complication of Injection

United States
Pharma VAM

Unknown

Clinical Study in the Treatment of Patients With COVID-19

COVID-19

Russian Federation
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Sarcoma | Ovarian Cancer | Brain Tumor | Ototoxicity | Neuroblastoma | Liver Cancer | Central Nervous System Tumor | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor

Canada, United States, Australia
Rigel Pharmaceuticals

No longer available

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Immune Thrombocytopenic Purpura
University of Southern California
National Cancer Institute (NCI)

Completed

IM-862 in Treating Patients With Recurrent Ovarian Cancer

Ovarian Cancer

United States
Tampere University Hospital
UMC Utrecht; Hungarian Academy of Sciences

Withdrawn

Oral Pyrophosphate Absorption in PXE Disease

Pseudoxanthoma Elasticum
Rigel Pharmaceuticals

Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Pneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia

United States, Argentina, Brazil, Mexico
AstraZeneca

Terminated

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Rheumatoid Arthritis

United States, Bulgaria, Mexico, Peru, Poland, Romania, Belgium, Germany, France, Italy, Colombia
Rigel Pharmaceuticals

Completed

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) (Taski-3)

Rheumatoid Arthritis

Belgium, United States, Colombia, France, Germany, Italy, Peru
Rigel Pharmaceuticals

Completed

Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

Purpura, Thrombocytopenic, Idiopathic

United States
Rigel Pharmaceuticals

Withdrawn

Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy

IGA Nephropathy
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaborators

Completed

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

Breast Cancer
Rigel Pharmaceuticals

Completed

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Immune Thrombocytopenic Purpura

Spain, United States, Australia, Poland, United Kingdom, Canada, Czechia, Bulgaria, Romania, Austria, Denmark, Hungary, Italy, Netherlands, Norway
Bellus Health Inc

Completed

A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes

Diabetes Mellitus, Type 2 | Metabolic Syndrome X

Canada
Rigel Pharmaceuticals

Withdrawn

Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus (SOLEIL)

Systemic Lupus Erythematosus
Rigel Pharmaceuticals

Completed

A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) (FIT)

Immune Thrombocytopenic Purpura

Spain, Norway, Poland, Czechia, Germany, United States, Austria, Bulgaria, Romania
Bayer

Completed

Primovist Post-marketing Surveillance in Japan (PRIMOVIST)

Diagnostic Imaging

Japan
Bayer

Completed

Primovist / Eovist in Renally Impaired Patients (PERI)

Contrast Media

United States, Germany, Italy, Korea, Republic of, Austria, Thailand, Australia, Spain, United Kingdom
Forbes Medi-Tech

Completed

Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia

Hypercholesterolemia

United States
Rigel Pharmaceuticals

Completed

A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) (FIT)

Immune Thrombocytopenic Purpura

United States, Australia, United Kingdom, Canada, Italy, Denmark, Hungary, Netherlands
Provectus Biopharmaceuticals, Inc.

No longer available

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory | Approved Alternative Therapy

United States, Australia
Provectus Pharmaceuticals

Completed

PV-10 Chemoablation of Recurrent Breast Carcinoma

Breast Cancer

New Zealand
Provectus Pharmaceuticals

Completed

Intralesional PV-10 Chemoablation of Metastatic Melanoma

Melanoma

Australia
Innovaderm Research Inc.
Abbott

Completed

Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

Sleep Apnea, Obstructive | Psoriasis

Canada

Search clinical trials for: Fospropofol disodium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations